Share of generics in selected European countries 2020

This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2020. The generic share in the pharmaceutical industry's market sales in Denmark stood at 35.5 percent. The market share of generics is higher in newer EU member states due to lower levels of intellectual property protection.

Market share of generics in selected European countries in 2020

Characteristic	Share of pharmaceutical market sales value
Italy	67.6%
Poland	58%
Austria	49%
Latvia	44%
Serbia	39.6%
Croatia	39%
Bulgaria	37%
Hungary	36.8%
Denmark	35.5%
Russia	31.6%
Turkey	28.8%
United Kingdom	28%
Czech Republic	26%
Greece	26%
Lithuania	24%
Sweden	23.4%
Slovenia	23.2%
Finland	23%
Germany	23%
Portugal	22.9%
Netherlands	22.5%
Norway	22.5%
Spain	22.2%
Romania	21%
Estonia	20.9%
France	19.5%
Slovakia	19.2%
Ireland	17.2%
Belgium	16.6%
Switzerland	13.7%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

2022

More information

Region

Europe

Survey time period

2020

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
Croatia, Czech Republic, Denmark, Estonia, Finland, Ireland, Hungary, Slovenia, U.K.: share of generics in pharmacy market sales Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Portugal, Spain: share of generics in reimbursable pharmacy market sales.
Austria, Belgium, France, Germany, Italy, Netherlands, Portugal, Slovenia, Spain: share of generics in reimbursable pharmacy market sales.
Bulgaria, Latvia, Lithuania, Norway, Poland, Romania, Russia, Serbia, Slovakia, Sweden, Switzerland, Turkey: share of generics in total market sales.
Latvia: 2019 data; Cyprus, Iceland, Malta: data not available.
France: data relate only to those active substances listed on the official list of medicines.
‘Generics’ are defined as medicines based on active substances that are out of patent and which are marketed under different names from that of the original branded medicines.

Citation formats